Background & context

None of this is required to apply — it’s here if you want to understand the space before you do.

← Back to the role

Broader industry context

How to stop bioterrorists from buying dangerous DNA

Bulletin of the Atomic Scientists

A non-technical, story-driven walkthrough of why screening a DNA customer as “legitimate” or not is genuinely hard, told through six fictional gene-synthesis customers.

In Support of Mandatory Nucleic Acid Synthesis Screening and Recordkeeping

Open letter

A short June 2026 open letter, signed by the CEOs of the major AI labs alongside Nobel laureates, national security experts, and DNA manufacturers, calling on Congress to make synthesis screening mandatory.

AI executives join call for stricter regulation of synthetic biology

Science

A neutral news summary of that open letter and the AI-driven concerns motivating the current push for mandatory screening and recordkeeping.

How to Secure the DNA Supply Chain

Institute for Progress

The most complete strategic overview of the field: why synthetic DNA is the key chokepoint, what “victory” looks like, and the main technical, policy, and coordination problems still unsolved.

Mitigating catastrophic biorisks

Kevin Esvelt (Effective Altruism)

A talk by one of SecureDNA’s co-founders laying out the norms and incentives around biotechnology, using DNA synthesis screening as the central example of how to reduce catastrophic risk.

Is That DNA Dangerous?

Asimov Press

A deeper explainer, written by two people who build screening tools, of how DNA screening algorithms actually work and how AI and benchtop synthesizers are changing the threat; it names SecureDNA directly.